381 related articles for article (PubMed ID: 32123960)
1. Evaluating primary intra-arterial chemotherapy versus intravenous plus intra-arterial chemotherapy for advanced intraocular retinoblastoma.
Chen Q; Zhang B; Dong Y; Mo X; Zhang L; Xia J; Zhang J; Zhang S
Cancer Chemother Pharmacol; 2020 Apr; 85(4):723-730. PubMed ID: 32123960
[TBL] [Abstract][Full Text] [Related]
2. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
Shields CL; Kaliki S; Al-Dahmash S; Rojanaporn D; Leahey A; Griffin G; Jabbour P; Shields JA
Retina; 2013; 33(10):2103-9. PubMed ID: 23873161
[TBL] [Abstract][Full Text] [Related]
3. Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3 months of age.
Chen Q; Zhang B; Dong Y; Mo X; Zhang L; Xia J; Zhang J; Zhang S
BMC Cancer; 2019 Jul; 19(1):693. PubMed ID: 31307410
[TBL] [Abstract][Full Text] [Related]
4. First-line intra-arterial versus intravenous chemotherapy in unilateral sporadic group D retinoblastoma: evidence of better visual outcomes, ocular survival and shorter time to success with intra-arterial delivery from retrospective review of 20 years of treatment.
Munier FL; Mosimann P; Puccinelli F; Gaillard MC; Stathopoulos C; Houghton S; Bergin C; Beck-Popovic M
Br J Ophthalmol; 2017 Aug; 101(8):1086-1093. PubMed ID: 27927678
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of primarily treated group D retinoblastoma.
Kiratli H; Koç İ; Inam O; Varan A; Akyüz C
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2225-2231. PubMed ID: 29961117
[TBL] [Abstract][Full Text] [Related]
6. Unilateral Retinoblastoma Managed With Intravenous Chemotherapy Versus Intra-Arterial Chemotherapy. Outcomes Based on the International Classification of Retinoblastoma.
Shields CL; Jorge R; Say EA; Magrath G; Alset A; Caywood E; Leahey AM; Jabbour P; Shields JA
Asia Pac J Ophthalmol (Phila); 2016; 5(2):97-103. PubMed ID: 26765038
[TBL] [Abstract][Full Text] [Related]
7. Intra-arterial chemotherapy combined with VEC intravenous chemotherapy in the treatment of advanced retinoblastoma.
Xu K; Liu J; Zhang C
J BUON; 2020; 25(2):1199-1205. PubMed ID: 32521926
[TBL] [Abstract][Full Text] [Related]
8. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
[TBL] [Abstract][Full Text] [Related]
9. Primary intravenous chemotherapy for group D retinoblastoma: a 13-year retrospective analysis.
Fabian ID; Stacey AW; Johnson KP; Onadim Z; Chowdhury T; Duncan C; Reddy MA; Sagoo MS
Br J Ophthalmol; 2017 Jan; 101(1):82-88. PubMed ID: 27965263
[TBL] [Abstract][Full Text] [Related]
10. Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis.
Chen Q; Zhang B; Dong Y; Mo X; Zhang L; Huang W; Jiang H; Xia J; Zhang S
BMC Cancer; 2018 Apr; 18(1):486. PubMed ID: 29703164
[TBL] [Abstract][Full Text] [Related]
11. Management of retinoblastoma in older children (>5 years) using intra-arterial chemotherapy: Comparison of outcomes to prechemotherapy and intravenous chemotherapy eras.
Selzer EB; Welch RJ; Jabbour P; Leahey AM; Shields CL
Indian J Ophthalmol; 2019 Dec; 67(12):2005-2011. PubMed ID: 31755439
[TBL] [Abstract][Full Text] [Related]
12. Ophthalmic Vascular Events after Primary Unilateral Intra-arterial Chemotherapy for Retinoblastoma in Early and Recent Eras.
Dalvin LA; Ancona-Lezama D; Lucio-Alvarez JA; Masoomian B; Jabbour P; Shields CL
Ophthalmology; 2018 Nov; 125(11):1803-1811. PubMed ID: 29921454
[TBL] [Abstract][Full Text] [Related]
13. Intra-arterial chemotherapy in refractory and advanced intraocular retinoblastoma.
Kumari N; Jain N; Saboo S; Parthasarathy R; Gupta V; Mahajan A; Das S
Indian J Ophthalmol; 2023 Feb; 71(2):436-443. PubMed ID: 36727336
[TBL] [Abstract][Full Text] [Related]
14. Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey.
Tuncer S; Sencer S; Kebudi R; Tanyıldız B; Cebeci Z; Aydın K
Acta Ophthalmol; 2016 Nov; 94(7):e644-e651. PubMed ID: 27214798
[TBL] [Abstract][Full Text] [Related]
15. Intra-Arterial Chemotherapy for Retinoblastoma: 8-Year Experience from a Tertiary Referral Institute in Thailand.
Rojanaporn D; Chanthanaphak E; Boonyaopas R; Sujirakul T; Hongeng S; Ayudhaya SSN
Asia Pac J Ophthalmol (Phila); 2019; 8(3):211-217. PubMed ID: 30714357
[TBL] [Abstract][Full Text] [Related]
16. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
Shields CL; Manjandavida FP; Lally SE; Pieretti G; Arepalli SA; Caywood EH; Jabbour P; Shields JA
Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
[TBL] [Abstract][Full Text] [Related]
17. The Efficacy of Alternate Systemic Intravenous Chemotherapy and Intra-arterial Chemotherapy Approach for Eye Globe Salvage in Retinoblastoma.
Han JW; Lee CS; Hahn SM; Ahn WK; Kim HS; Yun H; Lee SC; Kim BM; Kim DJ; Lyu CJ
Cancer Res Treat; 2023 Jan; 55(1):270-278. PubMed ID: 35609621
[TBL] [Abstract][Full Text] [Related]
18. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
Schaiquevich P; Ceciliano A; Millan N; Taich P; Villasante F; Fandino AC; Dominguez J; Chantada GL
Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125
[TBL] [Abstract][Full Text] [Related]
19. OPHTHALMIC VASCULAR EVENTS AFTER INTRA-ARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: Real-World Comparison Between Primary and Secondary Treatments.
Ancona-Lezama D; Dalvin LA; Lucio-Alvarez JA; Jabbour P; Shields CL
Retina; 2019 Dec; 39(12):2264-2272. PubMed ID: 30204728
[TBL] [Abstract][Full Text] [Related]
20. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.
Shields CL; Kaliki S; Shah SU; Bianciotto CG; Liu D; Jabbour P; Griffin GC; Shields JA
Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
